Paxalisib, temozolomide clinical trials

5G: A next generation agile genomically guided glioma modular platform for proof-of-concept molecular hypothesis testing in patients with malignant brain tumours

This study is testing a new drug called paxalisib with a standard treatment (temozolomide) for glioblastoma, a type of brain tumour. It aims to see if this combination is safe and effective, especially for patients whose tumours might respond well to paxalisib.